4 Einträge gefunden

1. Corrigendum to "Initial experience with CDK4/6 inhibitor-based therapies compared to antihormone monotherapies in routine clinical use in patients with hormone receptor positive, HER2 negative breast cancer - Data from the PRAEGNANT research network for the first 2 years of drug availability in Germany"

   1. Schneeweiss, Andreas
   2. Ettl, Johannes
   3. Lüftner, Diana
   4. Beckmann, Matthias W
   5. Belleville, Erik
   6. Fasching, Peter A
   7. Fehm, Tanja N

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
2. Initial experience with CDK4/6 inhibitor-based therapies compared to antihormone monotherapies in routine clinical use in patients with hormone receptor positive, HER2 negative breast cancer - Data from the PRAEGNANT research network for the first 2 years of drug availability in Germany

   1. Schneeweiss, Andreas
   2. Ettl, Johannes
   3. Lüftner, Diana
   4. Beckmann, Matthias W
   5. Belleville, Erik
   6. Fasching, Peter A
   7. Fehm, Tanja N

   2020 - Forschungsinformationssystem des UKE
3. Update Breast Cancer 2018 (Part 1) - Primary Breast Cancer and Biomarkers

   1. Taran, Florin-Andrei
   2. Schneeweiss, Andreas
   3. Lux, Michael P
   4. Janni, Wolfgang
   5. Hartkopf, Andreas D
   6. Nabieva, Naiba
   7. Overkamp, Friedrich

   2018 - Forschungsinformationssystem des UKE
4. Update Breast Cancer 2018 (Part 2) - Advanced Breast Cancer, Quality of Life and Prevention

   1. Schneeweiss, Andreas
   2. Lux, Michael P
   3. Janni, Wolfgang
   4. Hartkopf, Andreas D
   5. Nabieva, Naiba
   6. Taran, Florin-Andrei
   7. Overkamp, Friedrich

   2018 - Forschungsinformationssystem des UKE